MCK241129C445000
- 0.00
- 0.000.00%
McKesson Newsroom
Why McKesson (MCK) Is a Top Value Stock for the Long-Term
Biden Proposes Medicare, Medicaid Coverage of Obesity Drugs
Do Wall Street Analysts Like McKesson Stock?
McKesson Stock Gains 34.1% YTD: What's Driving the Rally?
McKesson Corporation (NYSE:MCK) Is Favoured by Institutional Owners Who Hold 89% of the Company
The US Oncology Network Launches Innovative Program to Foster Retention of New Oncology Nurses
Jefferies Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $715
Jefferies Sticks to Its Buy Rating for McKesson (MCK)
High Alpha Stocks That Are Rated 'Overweight' – MS
Jefferies Raises Price Target on McKesson to $715 From $607
J.P. Morgan Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $708
J.P. Morgan Sticks to Their Buy Rating for McKesson (MCK)
AZURITY PHARMACEUTICALS, INC ANNOUNCES FDA APPROVAL OF DANZITEN (Nilotinib) Tablets, THE FIRST AND ONLY NILOTINIB WITH NO MEALTIME RESTRICTIONS
McKesson's (NYSE:MCK) Conservative Accounting Might Explain Soft Earnings
InspiroGene by McKesson Partners With Vertex To Expand Distribution Of CASGEVY, The First FDA-Approved CRISPR Gene-Editing Therapy For Sickle Cell Disease And Β-Thalassemia
Investors Can Find Comfort In McKesson's (NYSE:MCK) Earnings Quality
McKesson Analyst Ratings
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?
Investors Heavily Search McKesson Corporation (MCK): Here Is What You Need to Know